Legal Opinion
United States ex rel. Rost v. Pfizer, Inc.
District Court, D. Massachusetts
Decided September 18, 2008No. Civil Action No. 03-11084-PBSPublishedCited by 14 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
SARIS, District Judge.
I. INTRODUCTION
Whistleblower Plaintiff Dr. Peter Rost, a former Vice President of Defendant Pharmacia, alleges that Pharmacia, a subsidiary of Defendant Pfizer, violated the federal False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq., and state law1 by unlawfully promoting the off-label use of the growth hormone medication Genotropin. Defendants have moved to dismiss the First Amended Complaint pursuant to Fed.R.Civ.P. 12(b)(6) and 9(b). After hearing, the motion is ALLOWED in part.
II. FACTS
The following facts are taken from the Amended Complaint and…
2Cases cited15 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Valerie Watterson v. Eileen PageCourt of Appeals for the First Circuit · 1993
- Jorge Correa-Martinez v. Rene Arrillaga-BelendezCourt of Appeals for the First Circuit · 1990
- Gagliardi v. SullivanCourt of Appeals for the First Circuit · 2008
- Centro Medico Del Turabo, Inc. v. Feliciano De MelecioCourt of Appeals for the First Circuit · 2005
10 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- United States Ex Rel. Nowak v. Medtronic, Inc.District Court, D. Massachusetts · 2011
- United States Ex Rel. Duxbury v. Ortho Biotech Products, L.P.Court of Appeals for the First Circuit · 2013
- United States Ex Rel. Carpenter v. Abbott Laboratories, Inc.District Court, D. Massachusetts · 2010
- United States ex rel. Booker v. Pfizer, Inc.District Court, D. Massachusetts · 2016
- United States ex rel. King v. Solvay S.A.District Court, S.D. Texas · 2011
9 more not listed; retrieve them via the Exa API.